MICRO THERAPEUTICS
Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases. It provides devices pertaining to the treatment of neurovascular disorders of the brain associated with stroke. It is also focused on the treatment of peripheral vascular disease, including blood clot therapy in hemodialysis access grafts, arteries, and veins. Its neurovascular product portfolio includes Sapphire and Sapphire NXT detachable coils that were developed to treat brain ane... urysms; Onyx, which is a liquid embolic that was developed to treat brain aneurysms and arterial-venous malformations; and delivery products, including guidewires, balloon catheters, and micro catheters, and more. It also provides a mechanical thrombolytic device for interventional clot disruption and dissolution. Micro Therapeutics was established in 1968, based in Irvine, California. It delivers its products to radiologists and neuroradiologists primarily in the United States, Canada, the European Union, and Japan. Micro Therapeutics currently operates as a subsidiary of Covidien plc.
MICRO THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Therapeutics
Founded:
1968-01-01
Address:
Irvine, California, United States
Country:
United States
Status:
Active
Similar Organizations
Advanced vascular Therapies
Advanced vascular Therapies provides non-invasive choices to individuals with poor circulation.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Metabolic Testing Services
MET-TEST offers a higher level of diagnostic insight to improve management of cardiac and pulmonary diseases.
MRI Robotics
MRI Robotics is dedicated to advanced medical devices for the diagnosis and treatment of cancer.
Target Therapeutics
Target Therapeutics develops disposable medical devices for use in minimally-invasive procedures that are used to treat vascular diseases.
Transmural Systems
Transmural Systems is a medical devices company with a platform of percutaneous structural heart therapies for cardiovascular diseases.
Zerusa
Zerusa Limited designs, develops and markets minimally invasive medical devises for the diagnosis and treatment of vascular disease.
Founder
Stock Details
More informations about "Micro Therapeutics"
Micro Therapeutics Company Profile 2025: Valuation, Investors ...
Micro Therapeutics General Information Description. Manufacturer of medical devices based in Irvine, California. The company's products include various medical devices and diagnostic …See details»
Micro Therapeutic Research Labs
About Us. We Are Leader In Industrial Market. Micro Therapeutic Research Labs Pvt. Ltd (MTRL) is a full service Clinical Research Organization (CRO) based in Chennai, Tamilnadu.See details»
ev3 Inc. And Micro Therapeutics, Inc. Announce Merger Agreement
Nov 14, 2005 About Micro Therapeutics, Inc. MTI develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disease. The …See details»
Micro Therapeutics - International Consortium of Investigative …
Micro Therapeutics Inc, Dba Ev3 Neurovascular, 9775 Toledo Way, Irvine CA 92618-1811 Manufacturer Parent Company (2017) Medtronic plc Manufacturer comment “If our …See details»
Micro Therapeutic Research Labs Private Limited | LinkedIn
Micro Therapeutic Research Labs Private Limited Research Services Chennai, Tamil Nadu 5,345 followersSee details»
Microbiome Therapeutics Innovation Group
The Microbiome Therapeutics Innovation Group (MTIG) is an independent 501(c)(6) coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to …See details»
Multi-Organ Microphysiological Systems for Drug Development: …
Techniques such as patch clamp and microelectrode arrays (MEA) have been developed to study the electrical activity of conductive tissues at the micro and meso scale. [ 129 , 130 ] While the …See details»
Micro Therapeutic Research Labs
Dr. M. Ganesan is the founder and Managing Director of Micro Therapeutic Research Labs Private Limited. He began his career as Trainee chemist in 1993 and became an entrepreneur, set-up his own research and development …See details»
MicroRNA therapeutics: Discovering novel targets and developing ...
Recent studies in animals and humans conducted in different laboratories present data that strengthen the candidature of miRNAs to establish the candidature of miRNAs to establish as …See details»
MicroRNA therapeutics: principles, expectations, and challenges
The substantial body of research over the last 10 years in the area of miRNA and cancer has increased our knowledge regarding the key roles of miRNA in cancer growth and progression. …See details»
Trials and Tribulations of MicroRNA Therapeutics - PMC
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS ... 1 Laboratory of Translational Oncology and Experimental Cancer …See details»
Developing MicroRNA Therapeutics | Circulation Research
Feb 3, 2012 Rarely a new research area has gotten such an overwhelming amount of attention as have microRNAs. Although several basic questions regarding their biological principles still …See details»
Therapeutic advances of miRNAs: A preclinical and clinical update
Feb 1, 2021 Micro-RNA inhibitors and their uses in disease ... understanding of miRNA and cancer biology, as well as an extensive IP portfolio. It is located in Austin, US. Mirna …See details»
Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for …
Sep 12, 2024 All these problems hinder the clinical application of protein therapeutics. Micro- and nano-particles based delivery platforms provide new opportunities to overcome those …See details»
The Challenges and Opportunities in the Development of …
Nov 9, 2021 The advances in understanding miR's role in disease, the development of efficient miR inhibitors, and innovative delivery approaches have helped resolve some of these …See details»
Trials and Tribulations of MicroRNA Therapeutics - MDPI
Jan 25, 2024 The discovery of the link between microRNAs (miRNAs) and a myriad of human diseases, particularly various cancer types, has generated significant interest in exploring their …See details»
Development of microRNA therapeutics is coming of age
MicroRNAs (miRNAs) play key regulatory roles in diverse biological processes and are frequently dysregulated in human diseases. Thus, miRNAs have emerged as a class of promising targets …See details»
Microbial therapeutics: New opportunities for drug delivery
The potential of microbial therapeutics is evident in the few existing live bacterial prophylactic vaccines and more recent work using fecal microbiota transplant (FMT) to cure recurrent …See details»
Minuscule Robots for Targeted Drug Delivery - www.caltech.edu
Dec 11, 2024 The final stage of development involved testing the microrobots as a drug-delivery tool in mice with bladder tumors. The researchers found that four deliveries of therapeutics …See details»
microRNA Therapeutics in Cancer — An Emerging Concept
Jul 11, 2016 MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding RNAs that negatively regulate protein coding gene and other non-coding …See details»